SpikImm SATT Sign License Deal for BK Virus Prevention
12 Jun 2025 //
BUSINESSWIRE
SpikImm initiates Trials for SPK001, its Monoclonal Antibody Against SARS-COV-2
20 Oct 2022 //
BUSINESSWIRE
SpikImm`s MAb Neutralises All SARS-COV-2 Variants of Concern
13 Apr 2022 //
BUSINESSWIRE
Spikimm and Institut Pasteur Announce Positive Result for SPKM001
08 Sep 2021 //
BUSINESSWIRE